drugset / Trial / NCT00157261

Thrombolysis Using Tenecteplase (Metalyse®) in Cardiac Arrest - The TROICA Trial

NCT00157261

Phase 3 Terminated 1050 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The general aim of this study is to compare the efficacy and safety of tenecteplase to standard treatment during cardiopulmonary resuscitation in patients suffering from out-of-hospital cardiac arrest.

Timeline

Start
2004-01
Primary completion
2006-06
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Tenecteplase Protein / enzyme biologic Intravenous

Indications